Daiwa Securities Group
ELVN icon

Daiwa Securities Group’s Enliven Therapeutics ELVN Stock Holding History

Daiwa Securities Group’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-152
Closed -$2K – 1263
2025
Q4 		$2K Hold
152
– – ﹤0.01% 1302
2025
Q3 		$3K Hold
152
– – ﹤0.01% 1238
2025
Q2 		$3K Hold
152
– – ﹤0.01% 1189
2025
Q1 		$3K Hold
152
– – ﹤0.01% 1161
2024
Q4 		$3K Hold
152
– – ﹤0.01% 1190
2024
Q3 		$4K Hold
152
– – ﹤0.01% 1182
2024
Q2 		$4K Hold
152
– – ﹤0.01% 1212
2024
Q1 		$3K Buy
+152
New +$2.33K ﹤0.01% 1236

Other funds holding ELVN

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return